openPR Logo
Press release

Global Pharmacovigilance Market & Forecasts

According to a new market research report published by Global Market Estimates, the Global Pharmacovigilance Market is expected to grow at a CAGR of 13.55% during the forecast period. The demand for pharmacovigilance is projected to be high due to the increasing demand for pharmacovigilance services and rising cost-effective initiatives for SMEs companies.

Browse 145 Market Data Tables and 118 Figures spread through 168 Pages and in-depth TOC on "Pharmacovigilance Market - Forecast to 2026"
https://www.globalmarketestimates.com/market-report/global-pharmacovigilance-market-2361

By Product Life Cycle (Pre-Clinical, Phase I, Phase II, Phase III, Phase IV), By Type of Service Provider (In-house, Contract Outsourcing), By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Therapeutic Area (Oncology, Neurology, Cardiology, Respiratory Systems, Others), By End-Use (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, Others), By Process Flow (Case Data Management, Signal Detection, Risk Management System), By Region (North America, Europe, Asia Pacific and Rest of the World); and Company Market Share Analysis & Competitor Analysis

Key Market Insights
• Pharmacovigilance is the study of science and practices involved in the diagnosis, awareness, review and prevention of adverse drug effects or other drug-related concerns
• The rising number of endemic diseases such as diabetes and respiratory disorders, among others
• The Phase IV segment will be the fastest-growing segment to hold the biggest market share in terms of revenue in the global market in terms of product life cycle from 2020 to 2026
• The in-house segment projected to grow faster at a highest CAGR than the contract-outsourcing in the global pharmacovigilance market in 2020-2026
• The Asia-Pacific will grow the fastest during the forecast period and North America as the largest segment in terms of revenue over the coming years
• Major players in the pharmacovigilance market include Wipro Ltd., Laboratory Corporation of America Holdings, ArisGlobal, ICON plc., Capgemini, IBM Corporation, ITClinical, FMD K&L, Accenture, IQVIA, TAKE Solutions Ltd., Linical Accelovance, Cognizant, PAREXEL International Corporation, BioClinica Inc., and United BioSource Corporation, among others.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-pharmacovigilance-market-2361

Product Life Cycle Outlook (Revenue, USD Million, 2020-2026)
• Pre-Clinical
• Phase I
• Phase II
• Phase III
• Phase IV

Type of Service Provider Outlook (Revenue, USD Million, 2020-2026)
• In-house
• Contract Outsourcing

Type Outlook (Revenue, USD Million, 2020-2026)
• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

Therapeutic Area Outlook (Revenue, USD Million, 2020-2026)
• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Others

End-Use Outlook (Revenue, USD Million, 2020-2026)
• Pharmaceuticals
• Biotechnology Companies
• Medical Device Manufacturers
• Others
Process Flow Outlook (Revenue, USD Million, 2020-2026)
• Case Data Management
• Signal Detection
• Risk Management System

Regional Outlook (Revenue, USD Million, 2020-2026)
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pharmacovigilance Market & Forecasts here

News-ID: 2162483 • Views: 330

More Releases from Global Market Estimates Research & Consultants

Liver Cancer Drugs Market Size - Forecasts to 2026
As per the research conducted by GME, the Liver Cancer Drugs Market will grow with a CAGR value of 18 percent by 2026. The rising incidence of liver cancer, government measures to raise cancer consciousness, and accelerated investments in research & development programs to produce innovative therapies are the primary forces driving the global liver cancer drugs market's expansion. Furthermore, due to people's acceptance of unsustainable lifestyles, a significant portion
Global Thalassemia Market Size – Forecast to 2026
The findings reviewed by GME stated that the Global Thalassemia Market will expand with a CAGR value of 10.2 percent from 2021 to 2026. Several drivers are likely to accelerate the thalassemia market further, including an increasing occurrence of thalassemia, growing public awareness, expanding expenditure in research & development, and the growing need for improved curative gene therapy. Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and
Head & Neck Cancer Therapeutics Market Size - Forecast to 2026
The findings reviewed by GME stated that the Global Head and Neck Cancer Therapeutics Market will expand with a CAGR value of 8.65 percent from 2021 to 2026. High consumption of tobacco and alcoholic beverages, a growing number of cases of target disorders, an aging population that has raised the incidence of chronic diseases, a growth in the pace of treatment protocols for head & neck cancer, and enhanced healthcare
Global Anterior Uveitis Treatment Market - Forecast to 2026
The findings reviewed by GME stated that the Global Anterior Uveitis Treatment Market will expand with a CAGR value of 5.4 percent from 2021 to 2026. The demand for anterior uveitis treatment is expected to rise over the projected period, due to the increasing prevalence of anterior uveitis, the growing geriatric population, greater investment in the production of novel biologics, and additional funding from private companies. Furthermore, advances in molecular

All 5 Releases


More Releases for Phase

2026 Global Pharmacovigilance Market Growth Analysis by Clinical Trials Like Pre …
Global Pharmacovigilance Market 2018 report includes extensive Market analysis and industry landscape along with SWOT analysis and PESTEL analysis of the important vendors. The analysis is conducted with a blend of secondary and primary advice for inputs from participants in the industry. Pharmacovigilance industry report covers the prospects of Women’S Health P oducts in the forecast period of 2018-2026 and the scenario. Growing prevalence of adverse reactions caused by drugs, has
Reverse Phase Columns (Professional Survey Report 2017)
"Global Reverse Phase Columns Market Professional Survey Report 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
MAAT Inaugurates Versatile Phase Shifter
Company announces release of a digital recreation of Roger Schult’s analog hardware MAAT Incorporated, a manufacturer of exceptional performance professional audio solutions, today announced the release of RSPhaseShifter version 1.0, a digital implementation of the Roger Schult/German Audio Lab’s Phase Shifter 500 Series W2324 hardware. The cross–platform plug–in creates a high quality, phase shifted version of a monaural or stereo input. Available in formats for all major DAWs (Digital Audio Workstations), RSPhaseShifter
Pre-Registration, Filing Rejected/Withdrawn, Phase Iii, Phase Ii, Phase I, Precl …
"Migraine - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine Pipeline Review, H2 2016, provides an overview of the Migraine (Central Nervous System) pipeline landscape. Migraine is a disorder characterized by repeated attacks of severe headache. A migraine headache causes throbbing or pulsating pain, usually on only one side of
Daisho Blacksmith completes successful Beta Test Phase
Huge support from users by brisk participation at beta test • Sync release could be further optimized • Official sync release shortly available as download Munich, february 23rd 2011. The beta test for the new version of the personal information management software DAISHO was successfully completed. Daisho Blacksmith, developer of the PIM tool, would like to thank the numerous testers which have actively contributed to the enhancement of DAISHO through their dedicated testing.
Epsilon Award 2008 - Nomination phase has started
The Epsilon Award is a combination of Excellency, craftsmanship and visionary ability. These are characteristics of an outstanding programmer and a piece of true software art. And you can now send your application for nomination for this prestigious award of our software industry. Please read all details and find the relevant signup link www.euroconference.org/Epsilon_Vote.htm on the webportal of the European Software Conference 2008, taking place in Berlin on November 8